Ryan Charles S. has filed 6 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 200000 shares of Quince Therapeutics, Inc. ($QNCX) on January 23, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2026 | Quince Therapeutics, Inc. | $QNCX | Ryan Charles S. | President | A | Employee Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 55,681,490 | 9999.99% | 0.36% |
| June 18, 2025 | Quince Therapeutics, Inc. | $QNCX | Ryan Charles S. | President | A | Common Shares | 7548 | $1.20 | 130,009.0000 | 44,001,643 | 6.16% | 0.02% |
| June 18, 2025 | Quince Therapeutics, Inc. | $QNCX | Ryan Charles S. | President | A | Warrants | 7548 | $0.13 | 7,548.0000 | 44,001,643 | 9999.99% | 0.02% |
| Jan. 28, 2025 | Quince Therapeutics, Inc. | $QNCX | Ryan Charles S. | PRESIDENT | A | Employee Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 20, 2024 | Quince Therapeutics, Inc. | $QNCX | Ryan Charles S. | PRESIDENT | P | Common Stock | 48387 | $0.65 | 122,461.0000 | 0 | 65.32% | 0.00% |
| Feb. 1, 2024 | Quince Therapeutics, Inc. | $QNCX | Ryan Charles S. | PRESIDENT | A | Employee Stock Option (right to buy) | 145000 | $0.00 | 145,000.0000 | 0 | 9999.99% | 0.00% |